Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Large Scale Safety Study of IMOVAX Polio in Selected Cities in China, an Observational Post Marketing Study

NCT01278433 is registered in ClinicalTrials.gov with Sanofi Pasteur, a Sanofi Company as lead sponsor.

NCT NCT01278433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01278433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Large Scale Safety Study of IMOVAX Polio in Selected Cities in China, an Observational Post Marketing Study
Lead sponsor
Sanofi Pasteur, a Sanofi Company
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2010
Completion date
June 30, 2012
Enrollment
5,007 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

polio, poliomyelitis